| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |